Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Fenofibrate (67mg) + Rosuvastatin (5mg) Tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Alu Alu
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Rosumore F 67 Tablet containing Fenofibrate and Rosuvastatin is used for the management of high cholesterol and triglyceride levels. It helps improve lipid balance and supports cardiovascular health.
Rosuvastatin works by reducing bad cholesterol and improving good cholesterol levels, while Fenofibrate helps lower triglycerides and supports healthy fat metabolism.
The tablet is widely prescribed in cardiac and general medicine practice for long-term lipid management therapy, leading to consistent prescription demand.
With increasing prevalence of lifestyle-related cardiovascular disorders and dyslipidemia, this product offers strong business potential for retailers and distributors. Its dual lipid-lowering action, broad clinical relevance, and steady market demand make it a reliable product for growth in the cardiac care segment.
Some patients may experience headache, nausea, abdominal discomfort, muscle pain, weakness, or constipation. Rarely, liver dysfunction, pancreatitis, or serious muscle-related complications such as myopathy may occur and require medical attention.
Rosumore F 67 Tablet is indicated for high cholesterol, mixed dyslipidemia, elevated triglycerides, and prevention of cardiovascular complications in patients with abnormal lipid levels. It helps reduce LDL cholesterol and triglycerides while improving HDL cholesterol levels.
This medicine should be used under medical supervision along with a healthy diet and regular exercise. Regular monitoring of liver function and lipid profile is recommended during treatment. Use cautiously in patients with liver, kidney, or gallbladder disorders.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75mg + Rosuvastatin 20mg + Clopidogrel 150mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Composition : Rosuvastatin 10mg + Clopidogrel 75mg Capsule
Composition : Rosuvastatin 10 mg + Ezetimibe 10 mg tablet
Composition : Rosuvastatin Calcium IP eq. to Rosuvastatin (as pellets) 20 mg. + Clopidogrel Bisulphate IP eq. to Clopidogrel 75 mg. Excipients q.s.
Composition : Rosuvastatin 5 mg tablet
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Rosumore F 67 Tablet, containing Fenofibrate 67mg and Rosuvastatin 5mg, has strong demand in the cardiometabolic and lipid management segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on cholesterol and heart health portfolios.
Medical distributors and agencies can benefit from the consistent demand for combination lipid-lowering therapy used in dyslipidemia, high cholesterol, hypertriglyceridemia, and cardiovascular risk management. Rosuvastatin helps reduce LDL cholesterol while Fenofibrate targets triglycerides, strengthening a comprehensive cardiac care product portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Rosumore F 67 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong chronic disease prescription demand, long-term cardiovascular therapy usage, reliable supply chain support, and good margins when partnering for Rosumore F 67 Tablet distribution.
Medical distributors, stockists, and wholesalers interested in Rosumore F 67 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.